African Americans carrying two copies of APOL1 G1 or G2 kidney risk alleles (referred to herein as APOL1 variant alleles) have a sevenfold increased risk for nondiabetic end-stage kidney disease and a 17-fold increased risk for focal segmental glomerulosclerosis, respectively2–4. Here, APOL1 is linked to focal segmental glomerulosclerosis.